Davis Polk advised the joint book-running managers and representatives of the underwriters on the $201 million public offering by BeiGene, Ltd. of American Depositary Shares. The ADSs are listed on the NASDAQ Global Select Market under the symbol “BGNE.”

BeiGene is a global, clinical-stage, research-based biotechnology company focused on targeted and immuno-oncological therapeutics.

The Davis Polk corporate team included partner Bruce K. Dallas and associates Jeffrey C. Lau and Dongbiao Shen. Partners John D. Paton and Rachel D. Kleinberg and associate Omer Harel provided tax advice. The intellectual property and technology team included partner Pritesh P. Shah and associate Paul S. Lee. Partner Nora M. Jordan provided Investment Company Act and Investment Advisers Act advice. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Northern California, New York and London offices.

Copy link to share post